Dexmedetomidine for Catheter-related Bladder Discomfort
NCT ID: NCT01991223
Last Updated: 2014-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
114 participants
INTERVENTIONAL
2013-11-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Dexmedetomidine and Glycopyrrolate Therapy
NCT05013320
Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort
NCT06399185
Effect of Dexmedetomidine on Microcirculation in Patients Undergoing Extracorporeal Shock Wave Lithotripsy
NCT01179438
Dexmedetomidine on Pediatric Heart Operation
NCT01920542
The Effect of Real-time Binaural Sound on Sedation Using Dexmedetomidine
NCT04866433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Dexmedetomidine is an alpha-2 antagonist and used as an analgesic agent. The investigators try to evaluate The efficacy of dexmedetomidine for the treatment of catheter-related bladder discomfort
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo group
NS infusion will be done during surgery.
NS infusion
Normal saline will be infused during surgery
Dex group
DEX infusion will be done during surgery.
Dex infusion
Dexmedetomidine will be injected (1 mcg/kg for 10 minutes and afterward 0.3 mcg/kg/hr)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dex infusion
Dexmedetomidine will be injected (1 mcg/kg for 10 minutes and afterward 0.3 mcg/kg/hr)
NS infusion
Normal saline will be infused during surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-III
Exclusion Criteria
* Patient with severe cardiovascular disease
* Patient with small-sized foley catheter (less than 18 Fr.)
* Patinets with any urinary tract obstructions
* Patient with hyperactive or neurogenic bladder
* Patients with chronic renal failure
* Patient with morbidly obese
* Patients with neurogenic disorder
* Patient with medications for chronic pain
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hee-Pyoung Park
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hee-Pyoung Park
Role: PRINCIPAL_INVESTIGATOR
Seoul National University of Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kim HC, Lee YH, Jeon YT, Hwang JW, Lim YJ, Park JE, Park HP. The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study. Eur J Anaesthesiol. 2015 Sep;32(9):596-601. doi: 10.1097/EJA.0000000000000196.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRBD_SNUH1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CRBD_DEX_PHPKHC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.